Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats.

Bimoclomol (BRLP-42) is a novel antiischemic compound acting against peripheral vascular complications of diabetes mellitus (neuropathy, retinopathy, and nephropathy). In the present study the activity of bimoclomol was tested in experimental subarachnoid hemorrhage (SAH) and arachidonic acid (AA)-i...

Full description

Bibliographic Details
Main Authors: Erdő Franciska
Erdo SL
Format: Article
Published: 1998
Series:BRAIN RESEARCH BULLETIN 45 No. 2
Subjects:
doi:10.1016/S0361-9230(97)00333-X

mtmt:2802864
Online Access:https://publikacio.ppke.hu/2337